Data / Drug companies / Cadila Pharmaceuticals Limited
Cadila Pharmaceuticals Limited: 34 products in the FDA NDC directory, labeler code 65691
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Cadila Pharmaceuticals Limited (labeler code 65691) lists 34 products in the FDA National Drug Code Directory. By type: 34 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on May 13, 2026.
The request: Watch Cadila Pharmaceuticals Limited (FDA labeler code 65691): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 65691
- Products in commercial distribution
- 34
- Packages
- 34
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 2
- Earliest marketing start
- October 31, 1994
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 34 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 34 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 33 | 97.1% |
| Liquid | 1 | 2.9% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Rivaroxaban | 65691-0128 | Powder | Bulk ingredients | May 13, 2026 |
| Labetalol hydrochloride | 65691-0091 | Powder | Bulk ingredients | May 12, 2026 |
| Gemfibrozil | 65691-0089 | Powder | Bulk ingredients | July 10, 2020 |
| Hydralazine hydrochloride | 65691-0088 | Powder | Bulk ingredients | July 3, 2020 |
| Venlafaxine hydrochloride | 65691-0126 | Powder | Bulk ingredients | September 19, 2015 |
| Aripiprazole | 65691-0052 | Powder | Bulk ingredients | September 11, 2015 |
| Bupropion hydrochloride | 65691-0103 | Powder | Bulk ingredients | December 31, 2014 |
| Carvedilol | 65691-0087 | Powder | Bulk ingredients | April 17, 2014 |
| Atorvastatin calcium form-i | 65691-0090 | Powder | Bulk ingredients | April 15, 2014 |
| Phthaloyl amlodipine | 65691-0127 | Powder | Bulk ingredients | January 30, 2014 |
| Nateglinide form-h | 65691-0083 | Powder | Bulk ingredients | June 21, 2013 |
| Raloxifene hydrochloride | 65691-0079 | Powder | Bulk ingredients | May 6, 2013 |
| Bosentan monohydrate | 65691-0084 | Powder | Bulk ingredients | March 5, 2013 |
| Valsartan | 65691-0065 | Powder | Bulk ingredients | July 7, 2012 |
| Paliperidone | 65691-0072 | Powder | Bulk ingredients | November 29, 2010 |
| Olmesartan medoxomil | 65691-0071 | Powder | Bulk ingredients | August 26, 2009 |
| Atomoxetine hydrochloride | 65691-0078 | Powder | Bulk ingredients | August 11, 2009 |
| Chlorhexidine gluconate solution | 65691-0051 | Liquid | Bulk ingredients | June 26, 2009 |
| O-desmethyl venlafaxine succinate | 65691-0067 | Powder | Bulk ingredients | January 22, 2009 |
| Escitalopram oxalate | 65691-0066 | Powder | Bulk ingredients | January 6, 2009 |
| Olanzapine form-i | 65691-0069 | Powder | Bulk ingredients | December 9, 2008 |
| Sildenafil citrate | 65691-0063 | Powder | Bulk ingredients | December 13, 2007 |
| Desloratadine | 65691-0057 | Powder | Bulk ingredients | December 11, 2007 |
| Nebivolol hydrochloride | 65691-0062 | Powder | Bulk ingredients | December 8, 2007 |
| Alendronate sodium | 65691-0056 | Powder | Bulk ingredients | July 11, 2007 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.